StapleBio Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.98M
- Investors
-
6
StapleBio General Information
Description
Operator of a biotechnology platform designed to develop treatments for diseases by targeting cellular and molecular mechanisms. The company offers drug discovery, biological research, therapeutic development, and technology for identifying disease mechanisms and potential drug targets to precisely regulate gene expression, enabling pharmaceutical researchers to develop new medicines for conditions with limited treatment options.
Contact Information
Website
www.staplebio.jpCorporate Office
- 2-39-1 Kurokami
- Chuoku
- Kumamoto, Kumamoto 860-8555
- Japan
Corporate Office
- 2-39-1 Kurokami
- Chuoku
- Kumamoto, Kumamoto 860-8555
- Japan
StapleBio Timeline
StapleBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 07-May-2024 | $2.98M | Completed | Startup | ||
| 2. Seed Round | 16-Dec-2022 | Completed | Startup | |||
| 1. Seed Round | 20-Jan-2022 | $609K | $609K | Completed | Startup |
StapleBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| S-Class Preferred | ||||||||
| S3 Class Preferred | ||||||||
| S2 Class Preferred | 62,668 | $7.23 | $7.23 | 1x | $7.23 | 15.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
StapleBio Patents
StapleBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025083626-A | Novel uses of staple nucleic acids | Pending | 21-Nov-2023 |
StapleBio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Diamond Medino Capital | Venture Capital | Minority | ||
| Mitsubishi UFJ Capital | Venture Capital | Minority | ||
| Sumisho Pharma International | Corporation | Minority | ||
| Higin Capital | Investment Bank | Minority | ||
| KSP (Kawasaki) | Corporation | Minority |
StapleBio FAQs
-
When was StapleBio founded?
StapleBio was founded in 2021.
-
Where is StapleBio headquartered?
StapleBio is headquartered in Kumamoto, Japan.
-
What industry is StapleBio in?
StapleBio’s primary industry is Drug Discovery.
-
Is StapleBio a private or public company?
StapleBio is a Private company.
-
What is the current valuation of StapleBio?
The current valuation of StapleBio is .
-
What is StapleBio’s current revenue?
The current revenue for StapleBio is .
-
How much funding has StapleBio raised over time?
StapleBio has raised $4.17M.
-
Who are StapleBio’s investors?
Diamond Medino Capital, Mitsubishi UFJ Capital, Sumisho Pharma International, Higin Capital, and KSP (Kawasaki) are 5 of 6 investors who have invested in StapleBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process